Literature DB >> 33871671

[Medical notification of occupational skin diseases by dermatologists].

S Krohn1, C Skudlik2,3.   

Abstract

In accordance with § 202 SGB VII, physicians in Germany have a legal obligation to report to the statutory accident insurance institution any justified suspicion of an occupational disease. With regard to skin diseases, various occupational disease numbers (Berufskrankheitennummer = BK No.) can be considered, depending on the type of disease and the type of exposure, e.g. BK No. 3101, 3102, 3104, BK No. 5102 and others in addition to the most common BK No. 5101 and BK No. 5103. The prerequisite for a well-founded suspicion is that occupational effects exist or existed which can be brought into a causal relationship with the skin disease. Form F6000 "Medical notification of a suspected occupational disease" is used for reporting. In the case of the numerically most significant BK No. 5101, there is the special feature that even if the skin disease is classified as occupationally caused, but not as severe or repeatedly relapsing, according to § 41 (1) of the contract between physicians and the accident insurance institutions, every physician is obliged to immediately present the insured person to a dermatologist so that the so-called dermatologist procedure can be initiated to enable the rapid initiation of prevention. Since 1 January 2021, it has been stipulated that the dermatologist's report must be submitted in every case-i.e. both when there is merely the possibility and when there is a well-founded suspicion of the existence of a BK No. 5101. This ensures that preventive measures can be quickly and effectively implemented.

Entities:  

Keywords:  Dermatologist procedure; Dermatologist report; Occupational dermatoses; Statutory accident insurance; Work-related skin diseases

Year:  2021        PMID: 33871671     DOI: 10.1007/s00105-021-04808-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  1 in total

1.  Occupational skin diseases.

Authors:  Thomas L Diepgen
Journal:  J Dtsch Dermatol Ges       Date:  2012-03-27       Impact factor: 5.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.